Caldera Therapeutics

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Bionyra

This biopharmaceutical company develops monoclonal and bispecific antibodies for patients with severe immune-mediated inflammatory diseases, specifically inflammatory bowel disease and atopic dermatitis.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

Aeglea BioTherapeutics

This company develops antibody therapies for patients living with inflammatory bowel disease and other immune-mediated conditions.

Altrubio

This clinical-stage biotechnology company develops antibody therapeutics to treat patients suffering from immunological and inflammatory diseases such as ulcerative colitis.

Belenos Biosciences

This clinical-stage biotechnology company develops long-acting bispecific antibody therapeutics for patients with chronic inflammatory diseases such as asthma and atopic dermatitis.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.

Granite Bio

This clinical-stage biotechnology company develops therapeutic antibodies to treat patients with inflammatory, autoimmune and fibrotic diseases.